Clinical Trial Update: MInimizing Delirium With Nasal Dexmedetomidine-InducEd Sleep (MIDDIES) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial (MIDDIES) evaluating intranasal dexmedetomidine-induced sleep to prevent postoperative delirium after major abdominal surgery; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Delirium
• Sleep Disturbance

Drugs mentioned

• Dexmedetomidine (intranasal) (dexmedetomidine)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Major Abdominal Surgery, Postoperative Delirium (POD) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING